These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

432 related items for PubMed ID: 26136200

  • 21. Elucidation of lactose fine size and drug shape on rheological properties and aerodynamic behavior of dry powders for inhalation.
    Sun Y, Yu D, Li J, Zhao J, Feng Y, Zhang X, Mao S.
    Eur J Pharm Biopharm; 2022 Oct; 179():47-57. PubMed ID: 36029939
    [Abstract] [Full Text] [Related]

  • 22. Formulating powder-device combinations for salmeterol xinafoate dry powder inhalers.
    Hassoun M, Ho S, Muddle J, Buttini F, Parry M, Hammond M, Forbes B.
    Int J Pharm; 2015 Jul 25; 490(1-2):360-7. PubMed ID: 25987210
    [Abstract] [Full Text] [Related]

  • 23. Evaluation of Granulated Lactose as a Carrier for Dry Powder Inhaler Formulations 2: Effect of Drugs and Drug Loading.
    Du P, Du J, Smyth HDC.
    J Pharm Sci; 2017 Jan 25; 106(1):366-376. PubMed ID: 27939234
    [Abstract] [Full Text] [Related]

  • 24. Impact of capsule type on aerodynamic performance of inhalation products: A case study using a formoterol-lactose binary or ternary blend.
    Wauthoz N, Hennia I, Ecenarro S, Amighi K.
    Int J Pharm; 2018 Dec 20; 553(1-2):47-56. PubMed ID: 30321640
    [Abstract] [Full Text] [Related]

  • 25. Powder flow analysis: A simple method to indicate the ideal amount of lactose fines in dry powder inhaler formulations.
    Hertel M, Schwarz E, Kobler M, Hauptstein S, Steckel H, Scherließ R.
    Int J Pharm; 2018 Jan 15; 535(1-2):59-67. PubMed ID: 29100914
    [Abstract] [Full Text] [Related]

  • 26. Evaluation of granulated lactose as a carrier for DPI formulations 1: effect of granule size.
    Du P, Du J, Smyth HD.
    AAPS PharmSciTech; 2014 Dec 15; 15(6):1417-28. PubMed ID: 24962007
    [Abstract] [Full Text] [Related]

  • 27. The effect of material attributes and process parameters on the powder bed uniformity during a low-dose dosator capsule filling process.
    Stranzinger S, Faulhammer E, Calzolari V, Biserni S, Dreu R, Šibanc R, Paudel A, Khinast JG.
    Int J Pharm; 2017 Jan 10; 516(1-2):9-20. PubMed ID: 27826028
    [Abstract] [Full Text] [Related]

  • 28. Performance tuning of particle engineered mannitol in dry powder inhalation formulations.
    Hertel N, Birk G, Scherließ R.
    Int J Pharm; 2020 Aug 30; 586():119592. PubMed ID: 32622814
    [Abstract] [Full Text] [Related]

  • 29. Influence of storage humidity on the in vitro inhalation properties of salbutamol sulfate dry powder with surface covered lactose carrier.
    Iida K, Hayakawa Y, Okamoto H, Danjo K, Luenberger H.
    Chem Pharm Bull (Tokyo); 2004 Apr 30; 52(4):444-6. PubMed ID: 15056961
    [Abstract] [Full Text] [Related]

  • 30. Effects of surface processing of lactose carrier particles on dry powder inhalation properties of salbutamol sulfate.
    Iida K, Inagaki Y, Todo H, Okamoto H, Danjo K, Luenberger H.
    Chem Pharm Bull (Tokyo); 2004 Aug 30; 52(8):938-42. PubMed ID: 15304985
    [Abstract] [Full Text] [Related]

  • 31. Understanding the effect of lactose particle size on the properties of DPI formulations using experimental design.
    Guenette E, Barrett A, Kraus D, Brody R, Harding L, Magee G.
    Int J Pharm; 2009 Oct 01; 380(1-2):80-8. PubMed ID: 19596428
    [Abstract] [Full Text] [Related]

  • 32. Freeze-dried mannitol for superior pulmonary drug delivery via dry powder inhaler.
    Kaialy W, Nokhodchi A.
    Pharm Res; 2013 Feb 01; 30(2):458-77. PubMed ID: 23070603
    [Abstract] [Full Text] [Related]

  • 33. Engineered mannitol as an alternative carrier to enhance deep lung penetration of salbutamol sulphate from dry powder inhaler.
    Kaialy W, Momin MN, Ticehurst MD, Murphy J, Nokhodchi A.
    Colloids Surf B Biointerfaces; 2010 Sep 01; 79(2):345-56. PubMed ID: 20537870
    [Abstract] [Full Text] [Related]

  • 34. The effects of loaded carrier mass and formulation mass on aerosolization efficiency in dry powder inhaler devices.
    Ooi J, Gill C, Young PM, Traini D.
    Curr Drug Deliv; 2015 Sep 01; 12(1):40-6. PubMed ID: 25146438
    [Abstract] [Full Text] [Related]

  • 35. Dry powder aerosols generated by standardized entrainment tubes from drug blends with lactose monohydrate: 1. Albuterol sulfate and disodium cromoglycate.
    Xu Z, Mansour HM, Mulder T, McLean R, Langridge J, Hickey AJ.
    J Pharm Sci; 2010 Aug 01; 99(8):3398-414. PubMed ID: 20198688
    [Abstract] [Full Text] [Related]

  • 36. Co-spraying of carriers (mannitol-lactose) as a method to improve aerosolization performance of salbutamol sulfate dry powder inhaler.
    Ferdynand MS, Nokhodchi A.
    Drug Deliv Transl Res; 2020 Oct 01; 10(5):1418-1427. PubMed ID: 31933129
    [Abstract] [Full Text] [Related]

  • 37. Investigations on the Mechanism of Magnesium Stearate to Modify Aerosol Performance in Dry Powder Inhaled Formulations.
    Jetzer MW, Schneider M, Morrical BD, Imanidis G.
    J Pharm Sci; 2018 Apr 01; 107(4):984-998. PubMed ID: 29247741
    [Abstract] [Full Text] [Related]

  • 38. Role of dispersion enhancer selection in the development of novel tratinterol hydrochloride dry powder inhalation formulations.
    Liu T, Tong S, Liao Q, Pan L, Cheng M, Rantanen J, Cun D, Yang M.
    Int J Pharm; 2023 Mar 25; 635():122702. PubMed ID: 36773729
    [Abstract] [Full Text] [Related]

  • 39. Modeling dispersion of dry powders for inhalation. The concepts of total fines, cohesive energy and interaction parameters.
    Thalberg K, Berg E, Fransson M.
    Int J Pharm; 2012 May 10; 427(2):224-33. PubMed ID: 22349053
    [Abstract] [Full Text] [Related]

  • 40. Dry powder inhalers: study of the parameters influencing adhesion and dispersion of fluticasone propionate.
    Le VN, Hoang Thi TH, Robins E, Flament MP.
    AAPS PharmSciTech; 2012 Jun 10; 13(2):477-84. PubMed ID: 22399285
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.